Fulgent Genetics, Inc. (FLGT) › Operating IncomeFulgent Genetics, Inc. (FLGT) — Operating IncomeAnnual figures by period end, from SEC filings.2014-12-31: -$990.0K2015-12-31: -$5.01M2016-12-31: $918.0K2017-12-31: -$3.48M2018-12-31: -$5.07M2019-12-31: -$428.0K2020-12-31: $290.16M2021-12-31: $675.95M2022-12-31: $178.53M2023-12-31: -$195.53M2024-12-31: -$73.92M2025-12-31: -$91.10M-$91.10M2014-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$91.10M—2026-02-27From 2025-01-012024-12-31-$73.92M—2026-02-27From 2024-01-012023-12-31-$195.53M-209.5%2026-02-27From 2023-01-012022-12-31$178.53M-73.6%2025-02-28From 2022-01-012021-12-31$675.95M+133.0%2024-02-28From 2021-01-012020-12-31$290.16M—2023-02-28From 2020-01-012019-12-31-$428.0K—2022-02-28From 2019-01-012018-12-31-$5.07M—2020-03-13From 2018-01-012017-12-31-$3.48M-479.3%2019-03-22From 2017-01-012016-12-31$918.0K—2018-03-20From 2016-01-012015-12-31-$5.01M—2017-03-17From 2015-01-012014-12-31-$990.0K—2017-03-17From 2014-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)